Emergency Number
Dr. Vivek Joshi 5819

Dr. Vivek Joshi

MBBS, DA, IDCCM, MCCR, PGCDM, PGDHM, CHQM Email: Department: Intensive and Critical Care

Qualification

Degree Year
MBBS 1997
Dip Anesthesia 2004
PGDHM 2007
IDCCM 2007
CHQM 2012

 

Publications

  • EYE CARE IN ICU: More than what meets the eye? Joshi V, at ESICM 2013, Paris [France] 07-10-2013
  • ET TUBE IN EMERGENCY: does size matter? Joshi V, at ESICM 2013, Paris [France] 07-10-2013
  • Nosocomial Meningitis: Does CSF lactate really help? Joshi V, at ESICM 2013, Paris [France] 07-10-2013
  • Sepsis in diabetes: Are RBS and HbA1C similar? Joshi V, at ESICM 2013, Paris [France] 07-10-2013
  • CAN FIXED NO. 7.5 ET TUBE SAVES LIVES BETTER IN EMERGENCY? Joshi V, Intensivist, Dept. of Critical Care Medicine, Rajshree hospitals, Indore, India. Published in ESICM journal 2012, Lisbon [Portugal]
    • Joshi V, J Nikhilesh, BK Abraham, Ramakrishnan N. “Outcome in sepsis :Does age really matter?: An audit was done to compare the mortality in sepsis between geriatric and non geriatric age group” Abstract 250 13th annual conference of Indian Society of critical care medicine Kochi, India Feb 2007
    • Joshi V, J Nikhilesh, BK Abraham Recombinant factor VIIa (rfVIIa) in non trauma settings: Holy Grail for bleeding in critical care unit. Abstract 25 Criticare Jan 2006
    • Joshi V, J Nikhilesh, BK Abraham, Use of activated recombinant factor VII in non traumatic bleed 77, Toronto Critical Care Medicine Symposium Oct 2005.
    • J Vivek , J Nikhilesh, Raja JR, BK Abraham, Ramakrishnan N. “Self extubation in critical care unit; quality of care initiative” . July 2005, 195. Scientific proceedings of Tamilnadu state Conference of Indian society of anesthesiologists (ISA) Hillcon, India ;

Membership

  • Executive Member, ISCCM Indore city Branch, (Certification and course with total credit hours – 196.30 hours)

Other Achievements

    RESEARCH EXPERIENCE:

  • Unblind investigator for phase III trial of TIMI AF trial to assess efficacy of new drug for Atrial Fibrillation at CARE Hospitals, Surat.
  • Use of activated recombinant factor VII in non traumatic bleed (Novoseven, Novartis)
  • Unblind investigator for the company FUJISAWA for phase II trial to assess efficacy of Micafungin v/s caspofungin for culture proven candidemia.

PRESENTATIONS/ POSTERS/AUDIT and RESEARCH EXPERINCE EYE CARE IN ICU: More than what meets the eye? Joshi V, due for presentation at ESICM 2013, Paris [France] 07-10-2013 :

  • ET TUBE IN EMERGENCY: does size matter? Joshi V, due for presentation at ESICM 2013, Paris [France] 07-10-2013
  • Nosocomial Meningitis: Does CSF lactate really help? Joshi V, due for presentation at ESICM 2013, Paris [France] 07-10-2013
  • Sepsis in diabetes: Are RBS and HbA1C similar? Joshi V, due for presentation at ESICM 2013, Paris [France] 07-10-2013
  • CAN FIXED NO. 7.5 ET TUBE SAVES LIVES BETTER IN EMERGENCY? Joshi V, Intensivist, Dept. of Critical Care Medicine, Rajshree hospitals, Indore, India. Presented at ESICM 2012, Lisbon [Portugal] on 16-10-2012.

Use of activated recombinant factor VII in non traumatic bleed at International conference organized by ISCCM (Indian society of Critical Care Medicine) Feb. 2006 Criticare, Chennai, India

“Outcome in sepsis :Does age really matters?: An audit was done to compare the mortality in sepsis between geriatric and non geriatric age group” Feb.2007 Criticare, Kochi, India (Awarded Best poster)

  • ‘Fungal infection in ICU’ the CME at Radisson hotel, Indore
  • ‘Critical incidents monitoring in ICU’ APMP, Bhopal
  • Critical Care Update – NIV workshop ISCCM Indore chapter 13 Nov 2011
  • Critical Care Update – ISCCM Indore chapter 12 Nov 2011
  • “Self extubation in critical care unit; quality of care initiative” July 2005 Tamilnadu state Conference of Indian society of anesthesiologists (ISA) Hillcon, India ;
  • ‘Pulse Oximetry & Capnography’ at PSMC, Karamsad, Gujarat 2003